Official 2024 U.S. DOL Form 5500 summary for Ipsen Biopharmaceuticals, INC (Ipsen Biopharmaceuticals, INC. U.s. 401(k) Plan · EIN 26-0042539 · PN 001): $205.81M net assets, 683 active participants, and $5.05 per $10,000 (5.05 bps).
| Plan Sponsor | Ipsen Biopharmaceuticals, INC |
|---|---|
| Filing Identifier | Ipsen Biopharmaceuticals, INC. U.s. 401(k) Plan · EIN 26-0042539 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (NJ) |
| Asset-Size Peer Cohort | $100M-$500M |
| Plan Net Assets (2024) | $205.81M |
| Active Participants | 683 |
| Direct Admin Fee Rate | $5.05 per $10,000 (5.05 bps) |
| Cohort Peer Median | $9.75 per $10,000 (9.75 bps) |
| Primary Recordkeeper / Provider | Fidelity Investments |
| Schedule H Line 4a Remittance | Timely Employer Remittance (0 reported on Line 4a) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI